Edelweiss Securities is hosting a conference call with the management of Natco Pharma to discuss the Company's Q4 FY22 financial results on Tuesday, May 31 2022 at 11.00 am, IST. Mr. Rajeev Nannapaneni, Director & Chief Executive Officer and Mr. Rajesh Chebiyam, Executive Vice President - Crop Health Sciences will represent Natco Pharma on the call.

Contact:

Kunal Randeria

Edelweiss Securities Ltd.

Tel: +91 22 6620 3040

Fax: +91 22 2286 4310

E-mail: kunal.randeria@edelweissfin.com

(C) 2022 Electronic News Publishing, source ENP Newswire